Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncolytic viruses: what's next?

John C Bell1

  • 1Ottawa Health Research Institute, 503 Smyth Road, Ottawa, Ontario, K1H 8L6, Canada. jbell@ohri.ca

Current Cancer Drug Targets
|March 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virus.

Molecular therapy. Oncology·2026
Same author

Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery.

Journal for immunotherapy of cancer·2026
Same author

Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma.

Cancers·2025
Same author

Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcoma.

bioRxiv : the preprint server for biology·2025
Same author

Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment.

Frontiers in immunology·2025
Same author

Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment.

Frontiers in immunology·2025

Oncolytic viruses (OVs) are a promising new cancer therapy. This article explores how OVs can revolutionize cancer treatment by targeting tumors in multiple ways, improving success rates.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Cancer's complexity and adaptability pose significant treatment challenges.
  • Current cancer therapies face limitations due to tumor evolution.
  • There is a need for innovative therapeutic strategies to improve cancer treatment outcomes.

Purpose of the Study:

  • To propose Oncolytic Viruses (OVs) as a new generation of smart therapeutics for cancer.
  • To highlight the potential of OVs to revolutionize cancer management.
  • To discuss the future development and applications of the OV platform.

Main Methods:

  • Review of current understanding of cancer's molecular biology.
  • Exploration of the OV platform's potential.
  • Speculation on future directions in OV development.

Related Experiment Videos

Main Results:

  • Oncolytic Viruses (OVs) demonstrate significant potential as targeted cancer therapeutics.
  • The OV platform offers a multi-pronged approach to combat cancer's adaptability.
  • Embracing OV technology is crucial for advancing cancer treatment.

Conclusions:

  • Oncolytic Viruses represent a powerful new tool in the fight against cancer.
  • Further development and application of OV technology are essential for improving patient outcomes.
  • The integration of molecular cancer biology with OV platforms promises future breakthroughs.